Nobunaga Xing and Liu Xiaotao meet with AstraZeneca's global CEO, Pascal Soriot.

According to the Intersecting Point News, on March 26, Secretary of the Jiangsu Provincial Party Committee Xinchangxing and Governor Liu Xiaotao met with Pascal Soriot, Global Chief Executive Officer of AstraZeneca in Nanjing. Xinchangxing said that he hopes AstraZeneca will see Jiangsu as the preferred location for increasing investment in the Chinese market, accelerating the introduction of new drugs, and increasing innovation investment, continuing to deepen cooperation in Jiangsu to achieve higher levels of mutual benefit. We will continue to create a market-oriented, rule-based, and international first-class business environment to provide high-quality services for companies to develop in Jiangsu. Soriot said that China's new blueprint for the "15th Five-Year Plan" has boosted global development confidence and AstraZeneca will actively seize new opportunities, continue to invest in China, deepen cooperation in Jiangsu, further improve the overall industry chain layout, provide better advanced medical and health services, and contribute to the construction of Healthy China and Healthy Jiangsu.